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OATP membrane transporters belong to carrier proteins responsible for transporting 
certain drugs (e.g. hypolipidemics from the group of statins) and other xenobiotics across 
the biological membranes and tissue barriers within the body. These transport proteins 
play an important role in pharmacokinetic processes such as absorption, distribution and 
elimination. The potential modulation of their transport function by natural compounds 
commonly present in plant food or food supplements may result in the changes of the 
concentration of their substrate (drug) in the cells and body fluids, that may affect the 
effect and toxicity of these drugs. 
The aim of this study was to obtain data on the interactions of selected natural 
compounds with human transporters OATP2B1 and OATP1A2 and their ability to affect 
drug transport mediated by these transporters. These two OATP transporters are 
involved in the drug uptake especially in organ barriers important for pharmacokinetics. 
For the study natural compounds from the group of flavonoids and isoflavones were 
selected. The common characteristics of studied flavonoids (fisetin, galangin, chrysin, 
myricetin, pinobanksin and pinocembrin) is their presence in the honey; studied 
isoflavones (daidzin, daidzein, genistin, genistein, glycitin, glycitein, biochanin A and 
formononetin) are mainly present in soya and soy products. The interaction of the most 
important isoflavone metabolites formed in gastrointestinal tract (S-equol, 
O-desmethylangolensin) with these transporters was also studied. The widely used 
hypolipidemic drug rosuvastatin served as model drug substrate of studied OATPs.  




Selected cell lines transiently transfected with studied OATP transporters served as 
experimental models. The overexpression of studied transporters was verified. These cell 
models were used for the inhibitory studies to examine the effect of selected flavonoids 
and isoflavones towards the transport function of the studied transporters. The standard 
inhibitory parameters IC50 and Ki were used for quantitative characterization. Flavonoid 
quercetin served as a comparator, because its inhibitory activity towards studied OATPs 
has been already described. We also analyze the mechanism of inhibitory interaction 
of studied transporters by selected natural compounds. The potential to influence drug 
transport was studied by observing of the effect of selected flavonoids on uptake 
of radiolabeled drug rosuvastatin. The comparison of flavonoid cytotoxicity in cells 
overexpressing studied transporters and mock-cells was performed as indirect method 
of determination whether the flavonoids are also potential substrates of these 
transporters. 
The results of in vitro inhibitory studies have shown that chrysin, galangin and 
pinocembrin are able to inhibit OATP2B1 and OATP1A2, respectively, at lower or 
comparable concentrations as quercetin. Galangin, chrysin and pinocembrin inhibited 
the rosuvastatin uptake mediated by OATP2B1 with the range of IC50 1–10 µM. 
The inhibition of rosuvastatin uptake mediated by OATP1A2 by these flavonoids was 
lower. In the case of soy isoflavones, aglycones and the main biologically active 
metabolite S-equol significantly inhibited the OATP2B1-mediated transport with Ki values 
1–20 µM. In contrast, glucoside forms did not exhibit statistically significant effect on 
OATP1A2-mediated uptake of standard substrate. The kinetic analysis not indicate the 
uniform type of inhibition of OATP by studied natural compounds, although predominant 
mechanism of inhibition seemed to be competitive especially in isoflavones. 
The transport of studied flavonoids by OATPs into the cells was not clearly proved by 
cytotoxicity assay.  
The obtained data has shown the ability of range of the studied natural compounds to 
inhibit the transport mediated by OATP2B1 and/or OATP1A2 transporter in vitro. These 
findings may suggest the potential to affect transport and modify pharmacokinetics 
of drugs transported by OATP across the biological membranes even in vivo. 
